Merck
Company www.merck.com ● Covered in 3 stories + Follow ✴ AI Graph
Merck describes itself as a research-intensive biopharmaceutical company focused on the development of medicines and vaccines. On its website, it presents areas including research, patients (information to guide health journeys), investors (financials, events, presentations, news, and stock information), and sustainability. It also highlights innovation via topics such as individualized neoantigen therapies, and provides a pipeline and clinical trials resources, along with media and contact information. The site states that Merck has been developing important medicines and vaccines for more than 130 years, and includes forward-looking statement language about pipeline and commercial outcomes being subject to risks and uncertainties.
Updated 9 September 2026
Public sources: Official website
Signals
—
Media momentum
As of 19 Oct 2026 · Visible stories in the last 30 days, compared with the 30 days before.
3 sources
Source diversity
As of 19 Oct 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 19 Oct 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
—
Funding signals
As of 19 Oct 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Jul 2026 → Aug 2026
Coverage span
As of 19 Oct 2026 · First to most recent month of TLDRocket coverage of this entity.
Management
updated 5 Aug 2026- Robert M. Davis President & CEO
- Sanat Chattopadhyay EVP & President, Merck Manufacturing Division
- Beth Perrone Senior Vice President, Chief Talent & Strategy Officer
- Fran Geatens Chief Technology Officer & Senior Vice President
- Brian Foard Executive vice president and president, Specialty, Pharma & Infectious Diseases
- Richard R. DeLuca Jr. EVP & President, Merck Animal Health
- Jennifer Zachary EVP, General Counsel & Corporate Secretary
- Gregg Szabo Senior Vice President, Merck, And President, Global Vaccines & Infectious Diseases
- Ellen Lambert Exec VP Merck Company Foundation
- Chirfi Guindo Executive Vice President, Strategic Access, Policy & Communications; Member of the Executive Team
- Richard DeLuca Executive Vice President and President Animal Health
- Jannie Oosthuizen President Global Oncology & MSD International
+ 26 more tracked
Latest developments
2026
Relationships
Partnerships
Products & technology
- Deploys FLIP2 · 1 source
- Develops mRNA cancer vaccine · 1 source
- Integrated with Keytruda · 1 source